English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Purpose: The aim of the study is to compare the expression of CD10 in invasive and non-invasive urothelial carcinomas. Methods: Primary sites of 40 cases of urothelial carcinomas were studied on H&E stained sections from the original biopsy paraffin block, out of them, 20 - with and another 20 – without smooth muscle invasion. For CD 10 expression routine immunohistochemical procedure was applied, using DAKO FLEX monoclonal mouse antihuman clon 56C6. Results: Two groups - invasive and non-invasive urothelial cancers were compared in regard to CD10 expression. The results definitely reveal that most of the cells in all invasive cancers express CD10, while in non-invasive cancers CD10 expresion was absent. Conclusion: The results provide convinsing evidense for CD10 role in urothelial cancer invasiveness in underlying smooth muscle.

Expression of CD10 as a prognostic and predictive factor in urothelial carcinomas